Published in World J Surg on September 26, 2002
Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer. World J Surg (2008) 2.15
Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg (2008) 1.18
Surgical treatment for liver cancer. World J Gastroenterol (2010) 0.96
Surgery for colorectal liver metastases: The evolution of determining prognosis. World J Gastrointest Oncol (2013) 0.95
Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature. Int J Colorectal Dis (2011) 0.93
Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) (2010) 0.90
The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases. Ann Surg Oncol (2014) 0.88
Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances. World J Gastroenterol (2016) 0.87
Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. HPB (Oxford) (2013) 0.87
Patient selection for hepatic resection for metastatic colorectal cancer. J Gastrointest Oncol (2012) 0.82
Impact of liver-directed therapy in colorectal cancer liver metastases. J Surg Res (2014) 0.82
Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases. HPB (Oxford) (2009) 0.82
Surgical treatment of hepatic metastases from colorectal cancer. World J Gastrointest Oncol (2011) 0.80
Metachronous liver metastases and resectability: Fong's score and laparoscopic evaluation. HPB (Oxford) (2008) 0.78
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial. BMC Cancer (2015) 0.78
External validation of two nomograms for predicting patient survival after hepatic resection for metastatic colorectal cancer. World J Surg (2011) 0.77
Segmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series. HPB (Oxford) (2012) 0.75
Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer. World J Surg (2008) 0.75
Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases. Ann Surg Oncol (2017) 0.75
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg (2000) 5.79
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96
Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol (1996) 3.52
Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery (1991) 3.35
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22
One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg (1991) 2.55
Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg (1997) 2.13
Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg (1995) 1.54
Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum (1999) 1.46
A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg (1997) 1.41
Resection of colorectal liver metastases: 25-year experience. World J Surg (1998) 1.36
Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol (1998) 1.26
Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg (1998) 1.24
Benefits and safety of hepatic resection for colorectal metastases. Am J Surg (1999) 1.16
Patient selection for hepatic resection of colorectal metastases. Arch Surg (1996) 1.13
Liver resection in the elderly. Br J Surg (1997) 1.01
Hepatic colorectal metastasis: current status of surgical therapy. Oncology (Williston Park) (1998) 0.96
Hepatic resections for colorectal metastases: the Italian multicenter experience. J Surg Oncol Suppl (1991) 0.95
Accurate specimen preparation and examination is mandatory to detect lymph nodes and avoid understaging in colorectal cancer. J Surg Oncol (1992) 0.81
A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum (2002) 2.53
Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum (2004) 2.01
[A pregnant woman with abdominal pain and fever]. Tidsskr Nor Laegeforen (2007) 1.49
Long-term prognosis after operation for adhesive small bowel obstruction. Ann Surg (2004) 1.40
DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset. PLoS One (2010) 1.26
Pain persists in many patients five years after removal of the gallbladder: observations from two randomized controlled trials of symptomatic, noncomplicated gallstone disease and acute cholecystitis. J Gastrointest Surg (2005) 1.04
Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients. Clin Cancer Res (2002) 1.04
Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas. Ann Surg Oncol (2012) 0.94
Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival. Surgery (2012) 0.94
Should we use laparoscopic adrenalectomy for metastases? Scandinavian multicenter study. J Surg Oncol (2009) 0.93
Health technology assessment in policy and practice. Working group 6 report. Int J Technol Assess Health Care (2002) 0.87
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma. Hepatology (2015) 0.87
Pancreatic surgery with vascular reconstruction in patients with locally advanced pancreatic neuroendocrine tumors. J Gastrointest Surg (2013) 0.86
Heterogeneity in gamma-glutamyltransferase mRNA expression and glycan structures. Search for tumor-specific variants in human liver metastases and colon carcinoma cells. Biochim Biophys Acta (2003) 0.82
Lipoteichoic acid is a potent inducer of cytokine production in rat and human Kupffer cells in vitro. Surg Infect (Larchmt) (2003) 0.80
Percutaneous cryoablation of colorectal liver metastases: potentiated by two consecutive freeze-thaw cycles. Cryobiology (2003) 0.79
Fibrinolysis during liver transplant and use of solvent/detergent virus-inactivated plasma (ESDEP/Octaplas). Anesth Analg (2003) 0.79
Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer. J Surg Oncol (2003) 0.79
Diagnosis and management of gallbladder calculus disease. Scand J Gastroenterol (2012) 0.78
[When new methods are about to be introduced]. Tidsskr Nor Laegeforen (2008) 0.78
Hepatic autotransplantation with ex situ neoplasm extirpation and vena cava replacement. Hepatogastroenterology (2003) 0.77
Liver tumor cryoablation: a commentary on the need of improved procedural monitoring. Technol Cancer Res Treat (2004) 0.77
Surgical treatment of sporadic pancreatic neuroendocrine tumors: a state of the art review. ScientificWorldJournal (2012) 0.76
Hepatic vascular inflow occlusion enhances tissue destruction during cryoablation of porcine liver. J Surg Res (2003) 0.76
[Surgical treatment of hormone-producing adrenocortical carcinoma with liver metastases]. Tidsskr Nor Laegeforen (2004) 0.75
[Surgery in liver metastases]. Tidsskr Nor Laegeforen (2008) 0.75
[Laparoscopic resection of the liver]. Tidsskr Nor Laegeforen (2002) 0.75
Hepatocellular carcinoma in a low-incidence region. Surgical perspectives. Dig Surg (2002) 0.75
[Extracorporeal surgery and liver autotransplantation]. Tidsskr Nor Laegeforen (2003) 0.75
The significance of heparin-coated veno-venous bypass circuits in liver transplantation. Perfusion (2002) 0.75
[Board of appeals for decision on reimbursement of expenses for medical treatment abroad]. Tidsskr Nor Laegeforen (2002) 0.75